Article Versions Notes

Gellert J, Jäkel A, Danielczyk A, Goletz C, Lischke T, Flechner A, Dix L, Günzl A, Kehler P. GT-00AxIL15, a Novel Tumor-Targeted IL-15-Based Immunocytokine for the Treatment of TA-MUC1-Positive Solid Tumors: Preclinical In Vitro and In Vivo Pharmacodynamics and Biodistribution Studies. International Journal of Molecular Sciences. 2024; 25(3):1406. https://doi.org/10.3390/ijms25031406

Gellert, Johanna, Anika Jäkel, Antje Danielczyk, Christoph Goletz, Timo Lischke, Anke Flechner, Laura Dix, Alexandra Günzl, and Patrik Kehler. 2024. "GT-00AxIL15, a Novel Tumor-Targeted IL-15-Based Immunocytokine for the Treatment of TA-MUC1-Positive Solid Tumors: Preclinical In Vitro and In Vivo Pharmacodynamics and Biodistribution Studies" International Journal of Molecular Sciences 25, no. 3: 1406. https://doi.org/10.3390/ijms25031406

Gellert, J., Jäkel, A., Danielczyk, A., Goletz, C., Lischke, T., Flechner, A., Dix, L., Günzl, A., & Kehler, P. (2024). GT-00AxIL15, a Novel Tumor-Targeted IL-15-Based Immunocytokine for the Treatment of TA-MUC1-Positive Solid Tumors: Preclinical In Vitro and In Vivo Pharmacodynamics and Biodistribution Studies. International Journal of Molecular Sciences, 25(3), 1406. https://doi.org/10.3390/ijms25031406